Updated Jul 16, 2026
KLEIN JOSEPH III has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $6.72M.

| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-06 | IONS | IONIS PHARMACEUTICALS INC | S — Open-market sale | 11.4K | $79.04 | $903K |
| 2026-07-06 | IONS | IONIS PHARMACEUTICALS INC | S — Open-market sale | 99 | $79.45 | $8K |
| 2026-07-06 | IONS | IONIS PHARMACEUTICALS INC | M — Option exercise | 11.5K | $39.94 | $460K |
| 2026-05-05 | IONS | IONIS PHARMACEUTICALS INC | S — Open-market sale | 1.4K | $74.45 | $107K |
| 2026-05-05 | IONS | IONIS PHARMACEUTICALS INC | S — Open-market sale | 8.7K | $73.35 | $637K |
| 2026-05-05 | IONS | IONIS PHARMACEUTICALS INC | M — Option exercise | 10.1K | $47.11 | $476K |
| 2026-04-02 | IONS | IONIS PHARMACEUTICALS INC | S — Open-market sale [10b5-1] | 2.2K | $75.95 | $168K |
| 2026-04-02 | IONS | IONIS PHARMACEUTICALS INC | S — Open-market sale [10b5-1] | 20.1K | $75.50 | $1.52M |
| 2026-04-02 | IONS | IONIS PHARMACEUTICALS INC | M — Option exercise [10b5-1] | 10.3K | $41.08 | $424K |
| 2026-04-02 | IONS | IONIS PHARMACEUTICALS INC | M — Option exercise [10b5-1] | 12.0K | $38.06 | $457K |
| 2026-03-05 | IONS | IONIS PHARMACEUTICALS INC | S — Open-market sale [10b5-1] | 1.0K | $80.82 | $82K |
| 2026-03-05 | IONS | IONIS PHARMACEUTICALS INC | S — Open-market sale [10b5-1] | 6.8K | $80.00 | $543K |
| 2026-03-05 | IONS | IONIS PHARMACEUTICALS INC | S — Open-market sale [10b5-1] | 13.5K | $79.17 | $1.07M |
| 2026-03-05 | IONS | IONIS PHARMACEUTICALS INC | M — Option exercise [10b5-1] | 4.0K | $42.88 | $172K |
| 2026-03-05 | IONS | IONIS PHARMACEUTICALS INC | M — Option exercise [10b5-1] | 12.0K | $40.05 | $481K |
| 2025-09-03 | IONS | IONIS PHARMACEUTICALS INC | S — Open-market sale | 28.0K | $60.00 | $1.68M |
| 2025-09-03 | IONS | IONIS PHARMACEUTICALS INC | M — Option exercise | 12.0K | $0.00 | |
| 2025-09-03 | IONS | IONIS PHARMACEUTICALS INC | M — Option exercise | 16.0K | $0.00 |
KLEIN JOSEPH III is a corporate insider — currently tracked as Director of IONIS PHARMACEUTICALS INC (IONS). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 10 open-market sales ($6.72M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live KLEIN JOSEPH III profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.